How to Build a Period Tracking App: Cost, Features, and Data Privacy

A wellness director at a 6,000-employee healthcare system is piloting a women's health benefit. She selects Flo for Work, runs it through legal review, and gets a flag back from the privacy team: Flo's terms of service permit sharing anonymized data with third-party analytics partners. The company's general counsel recommends against enrolling employees on a platform where menstrual cycle data could exit the organization's control. In a state with restrictive reproductive health laws, even anonymized cycle data carries litigation exposure.

That scenario, and ones like it, is what sends employers, digital health startups, and OB/GYN practices to a custom build. Not because Flo is a bad product. It isn't. But its business model depends on data monetization, which means it cannot offer the data architecture that a risk-aware employer benefits program requires.

Here is what a custom period tracking app actually costs, what it requires to build well, and where most teams get it wrong.

How much does it cost to build a period tracking app?

An MVP with cycle tracking, symptom logging, HIPAA-compliant data handling, and notification reminders costs $50K-$80K in 12-16 weeks. A full platform with fertility prediction, wearable integration, and AI-based cycle analysis runs $120K-$220K in 24-36 weeks.

These ranges assume a team of 2-3 engineers, a product designer, and a QA engineer. They include a reproductive data privacy architecture from day one, which is not optional for any deployment in the current legal environment.

Who actually builds a custom period tracking app?

Flo has more than 300 million registered users. Clue has over 12 million monthly active users. For general-purpose cycle tracking, these products are genuinely strong. A custom build makes sense only when a specific integration requirement, data privacy obligation, or population need falls outside what a consumer app can support.

Four operator types consistently reach that threshold.

Employer wellness programs that want to offer menstrual health tracking as a benefits feature face a structural problem with consumer apps. Flo and Clue are ad-supported or freemium products that depend on data scale. Their terms do not match what a corporate benefits program needs: SSO integration with the company's identity provider, utilization reporting that the benefits committee can review, and a data handling agreement that satisfies a corporate privacy team. None of these exist in a standard consumer app subscription.

Digital health startups building in the reproductive health space sometimes choose privacy architecture as their core product differentiator. After the Electronic Frontier Foundation documented the data exposure risk of consumer period apps in 2022, several startups positioned on the premise that they would not collect, sell, or share menstrual data. That promise requires custom architecture, not a reskin of an existing consumer SDK.

Women's health clinics and OB/GYN practices adding patient-facing tracking to their practice management system have a different set of requirements: cycle data needs to integrate with the practice's EHR, appointment reminders should connect to the scheduling system, and any symptom logs that suggest a clinical concern need a pathway to a provider review. A consumer app cannot route data back to a clinical workflow.

Consumer apps targeting specific populations face a different limitation. Flo's prediction algorithm is trained on the general population. Women with PCOS have highly irregular cycles that standard rule-based prediction handles poorly. Women who are perimenopausal have cycles that may be 20-60 days apart. Women with endometriosis have symptom profiles that general symptom libraries do not capture. Building for a specific population requires training data and a clinical input layer that a general-purpose product cannot provide.

Flo, Clue, and Natural Cycles vs. custom period tracking software

Before scoping a build, you should know exactly when each consumer option stops working.

Flo is the right choice for standard personal cycle tracking. With over 300 million registered users, Flo has a prediction model with more training data than any custom build will have in its first 2-3 years. The symptom library covers the most common menstrual experiences. For an individual woman tracking her own cycle with no privacy requirements beyond her own, Flo is the best-in-class product.

Clue is the right choice for women who prioritize a science-backed, non-stigmatizing approach to menstrual health. Clue's data model emphasizes clinical accuracy and the app has published peer-reviewed research on menstrual cycle patterns. Clue's premium tier (EUR 3.99/month) is priced for individual subscribers, not employer programs.

Natural Cycles is the right choice specifically for women using fertility awareness as a contraceptive method. It is the only period tracking app with FDA clearance as a contraceptive (Class II Software as a Medical Device, cleared in 2018). That clearance took several years and significant clinical validation. It is the reference point for any team considering building a contraceptive app. If you are not building a contraceptive specifically, Natural Cycles' regulatory overhead is not relevant to your build.

Build custom when you hit any of these conditions:

1. You need SSO with an employer's identity provider, which means no consumer app can gate access to the benefit correctly.
2. You need a data handling model that prohibits third-party SDK access to menstrual cycle data.
3. Your target population has irregular cycles, specific clinical conditions (PCOS, endometriosis, perimenopause), or hormone use patterns that a general prediction algorithm handles poorly.
4. You need aggregate utilization reporting for a benefits program or a payer contract.
5. You are integrating with an EHR or a practice management system.

Period tracking app features: V1, V2, V3

V1: Launch (12-16 weeks, $50K-$80K)

The push notification requirement is worth specific attention. Apple and Google deliver push notification payloads through their servers. A notification that includes "Your period is 2 days away" sends menstrual health data through a third-party infrastructure. The correct implementation sends a generic notification ("You have a reminder in the app") and renders the personalized content only after the user opens the app and data decrypts locally.

V2: Fertility and wearable layer (adds 12-16 weeks, $40K-$80K)

V3: Clinical and employer layer (adds 16-24 weeks, $50K-$80K)

Reproductive data privacy: the defining challenge

This section matters more for a period tracking app than for any other category of women's health software. The reason is specific: menstrual cycle data is a proxy for reproductive intent, and in the current US legal environment, that data carries litigation risk that most health data does not.

The Dobbs decision changed the risk landscape

The Supreme Court's ruling in Dobbs v. Jackson Women's Health Organization (2022) overturned Roe v. Wade and returned abortion regulation to the states. The practical consequence for period tracking apps: in states with abortion restrictions, menstrual cycle data could theoretically be sought in legal proceedings. A missed period, a pregnancy log, or a cycle anomaly notification stored in an app could be relevant in a criminal investigation under a restrictive state law.

As the Georgetown Law Center on Reproductive Rights and Health noted in a 2022 analysis, the potential use of digital data, including period tracking data, in abortion-related enforcement is a documented legal concern, not a theoretical one.

Consumer period apps are not HIPAA covered entities. HIPAA applies to healthcare providers, health plans, and their business associates. A consumer app that has no relationship with a covered entity handles data outside HIPAA's protection. That means the privacy protections users assume from "health app" branding may not exist.

The FTC's enforcement record

The FTC has taken enforcement action against period tracking apps specifically. In 2023, the FTC settled with Premom (maker of the Premom ovulation tracking app) for sharing users' sensitive health data, including reproductive health information, with third-party analytics companies without clear user disclosure. The settlement required data deletion and imposed restrictions on future data sharing.

The FTC's 2021 report on commercial surveillance specifically flagged period and fertility apps as high-risk categories for sensitive health data misuse. Apps that share location data combined with menstrual cycle data with advertising networks give those networks enough information to infer reproductive intent.

What the architecture response looks like

A privacy-first period tracking app requires specific technical decisions that most consumer apps have not made, because those decisions conflict with advertising-based monetization:

Dedicated encrypted partition for reproductive data. Cycle logs, period dates, pregnancy indicators, and symptom notes should live in a separate encrypted store, distinct from the general user profile. This allows for targeted data deletion without affecting account data, and limits the blast radius of any data breach.

No third-party ad or analytics SDKs with access to cycle data. Common analytics SDKs (Firebase, Amplitude, Mixpanel) can be configured to exclude sensitive data fields. This must be enforced in the implementation, not assumed. No advertising SDK should receive any event that contains or derives from menstrual cycle data.

User-initiated data deletion within 30 days. Users must be able to delete all reproductive health data. The deletion must be verifiable and complete. A maximum 30-day retention window after a deletion request is a defensible standard. Document the deletion process technically, not just in the privacy policy.

Legal hold response policy. If the app receives a court order or law enforcement request for user data, the default response should be to decline without a valid court order and to notify the user if legally permitted. This policy should be documented and reviewed by legal counsel before launch. Several privacy-forward apps have published data transparency reports and explicit policies on law enforcement requests.

No PHI in push notification payloads. As described in the V1 section: generic notification text, personalized content only after in-app decryption.

This privacy architecture is the product differentiator that consumer apps cannot credibly offer. Flo and Clue's business models depend on data at scale. A custom build can make architectural choices that a consumer app with 300 million users and an ad-supported revenue model cannot.

The cycle prediction algorithm

The algorithm is where user trust lives. An app that predicts a period date off by 5 days gets uninstalled. An app that consistently gets it right within 1-2 days becomes a daily habit.

There are three approaches, each with different cost and accuracy profiles.

Rule-based prediction calculates the average cycle length from logged historical cycles and adds that number to the last period start date. It works well for women with regular cycles (consistent within 2-3 days cycle to cycle). It fails for women with irregular cycles, including those with PCOS, perimenopause, or recent hormonal contraceptive use. Implementation cost: $5K-$8K added to the build.

Statistical models use the distribution of historical cycle lengths, rather than just the average, to output a predicted date with a confidence range. Instead of "your period is predicted for July 21," the user sees "your period is likely between July 19-23." For women with moderate variability, a range prediction is more honest and builds more trust than a point estimate that frequently misses. Statistical modeling adds $8K-$15K to the build.

ML-based models train on the individual user's full history of logged cycles, symptoms, and (if available) wearable biometric data. They improve over time as more data accumulates. The tradeoff: the model needs 6-12 months of consistent logging before it outperforms a well-tuned statistical model for a given user. For irregular cycle users, the ML model is worth the investment because rule-based methods are genuinely inadequate. Building and maintaining an ML model adds $20K-$30K upfront for the data pipeline and training infrastructure, plus $1K-$3K/month for ongoing inference and model retraining.

Wearable data integration improves ovulation prediction specifically, not period prediction. Resting heart rate data from an Apple Watch and heart rate variability (HRV) data from an Oura Ring both correlate with the hormonal shifts around ovulation. This is useful for women trying to conceive, where identifying the fertile window matters more than period date prediction. Wearable integration adds $15K-$25K to the build cost and requires maintaining API integrations with Apple HealthKit and the Oura API (both of which version and change).

One point worth being direct about: building a custom ML model with a small initial user base will not immediately outperform Flo or Clue. Their models are trained on data from millions of cycles. Your V1 model will be less accurate. The argument for the custom build is not algorithmic accuracy in year one. It is the privacy architecture, the employer integration, or the population-specific focus that a consumer app cannot offer.

How period tracking apps make money

Freemium subscription is the dominant model. Flo offers basic tracking free and charges for Flo Premium (access to health insights, ad-free experience, health library). Flo's estimated annual revenue in 2023 was over $200 million, according to data from Business of Apps. Clue charges approximately EUR 3.99/month for its premium tier.

Employer and payer B2B contracts offer higher contract values than consumer subscriptions. An employer wellness program typically pays $2-$6 per employee per month (PEPM) for a women's health benefit. A 5,000-person employer at $4 PEPM generates $240K per year from one contract. Sales cycles are longer (3-9 months), but contract values are more predictable than consumer churn.

Research partnerships with academic institutions or pharmaceutical companies can provide revenue through de-identified population data. The privacy caveats are significant: any research data sharing program requires informed consent, IRB review if a covered entity is involved, and a rigorous de-identification process. The Georgetown Law reproductive rights framework and the FTC's position on health data make this revenue stream higher-risk than it was before 2022.

The global femtech market was valued at $51 billion in 2023 and is projected to reach $103 billion by 2030, according to Grand View Research. Period tracking and menstrual health apps represent the largest segment of that market by user volume. Fertility and prenatal are the fastest-growing by revenue per user.

How RaftLabs builds period tracking apps

"The privacy architecture is not a compliance checkbox in women's health apps. It is the product," says Ashit Vora, co-founder of RaftLabs. "When an employer wellness program or a startup positions on privacy, that promise has to be enforced at the data layer from the first sprint. You cannot retrofit a privacy-first architecture onto a product that was built with standard analytics SDKs and a shared data model. It is a rearchitecture, not a configuration."

We have built clinical-grade digital health products across telehealth, patient engagement, and employer wellness. For menstrual health platforms specifically, we start with a data architecture session before wireframe work: mapping what data is collected, where it is stored, what third-party services touch it, and what the legal hold response process looks like. That session determines the build scope and the compliance posture from day one.

If you are building a period tracking app for an employer benefits program, a digital health startup where privacy is the product differentiator, or a clinical practice adding patient-facing tracking to your workflow, book a 30-minute scoping call. We will scope the V1, tell you what the cycle algorithm requires for your target population, and identify where the privacy architecture adds cost before you commit to a build.